NEW YORK (GenomeWeb) – Cartagenia said this week that it intends to use €4.3million ($5.9 million) in private financing to grow its business and to hire between 20 and 30 sales and support staff for its offices in Boston and Leuven, Belgium.

NEW YORK (GenomeWeb) – San Diego-based Med Data Quest is hoping to build a business around providing natural language processing and statistical modeling tools that can extract and use information from electronic medical records to help physicians accurately diagnose diseases and suggest more eff

NEW YORK (GenomeWeb) – Genedata said this week that GlaxoSmithKline's biopharma research and development arm has selected its Genedata Biologics software to handle data management and workflow support needs.

Horridge M, Musen MA, et al. WebProtege: A Collaborative Web Based Platform for Editing Biomedical Ontologies. Bioinformatics. 2014 Apr 26. [Epub ahead of print]

MedPage Today and CollabRx have released CancerRx, an application that runs on Apple's operating system, that’s designed to help oncologists and pathologists navigate the complex landscape of oncology therapeutic options.

The International Society for Computational Biology has awarded the 2014 Senior Scientist Award to Eugene Myers of the Max Planck Institute of Molecular Cell Biology and Genetics.

NEW YORK (GenomeWeb) – By the time the fall semester rolls around at Duke University this year, the school's decade-old flagship genomics program, the Institute for Genome Sciences and Policy, will be gone

NEW YORK (GenomeWeb) – Appistry said today that it has signed a deal to include Personal Genome Diagnostics' CancerSelect panel in the recently released Appistry CloudDx genomics testing service.

NEW YORK (GenomeWeb) – Ascendant Dx said this week it has named Patricia Beckmann as CSO and chief business officer, and that Mark Boguski and Isaac Kohane have joined its scientific advisory board.

NEW YORK (GenomeWeb News) – Two independent research groups this week published mass spec-based draft maps of the human proteome.

NEW YORK (GenomeWeb News) – Health Diagnostic Laboratory plans this summer to begin running studies of biomarkers comprising its Diabetes Prevention and Management Panel using clinical samples obtained in its purchase of assets from defunct diagnostics firm Tethys Bioscience.

NEW YORK (GenomeWeb News) – Aiming to establish a framework for the analysis of organelle proteomics data, researchers at the Cambridge Centre for Proteomics have published a study detailing best practices for the field.

Proteome Sciences this week posted 2013 revenues of £2.14 million ($3.59 million), up 86 percent from £1.15 million in 2012.

In Print: Recent Proteomics Papers of Note Journal: PLOS One, April 7 Title: Top-down proteomics with mass spectrometry imaging: A pilot study towards discovery of biomarkers for neurodevelopmental disorders.

Meso Scale Discovery has released its S-PLEX immunoassay platform, which, the company said, is 1,000 times more sensitive than existing ELISA technologies and can detect analytes at concentrations below 1 femtogram per mL.

Singulex has appointed Peter Heseltine as chief medical officer.

As the PSI rides into the sunset, some parts may be worth preserving.

Volumes of next-gen sequencing data have one biologist living "a paired-end nightmare."

In Science this week: rat brain synapse visualization and more.

The Onion takes on pay disparity in STEM fields.

NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has inked a partnership with South Korea's Center for Women in Science, Engineering and Technology to help advance women scientists and engineers in that country.

This article has been updated from a previous version as Qiagen clarified an earlier statement regarding its acquisition of PrimeraDx.

NEW YORK (GenomeWeb) – Agilent Technologies' Dako business said today that it will develop a companion diagnostic test for a cancer drug being developed by Merck.

NEW YORK (GenomeWeb) – Sangamo BioSciences today said that the California Institute for Regenerative Medicine has awarded $5.6 million grant to researchers at City of Hope to develop an HIV/AIDS therapeutic based on Sangamo's zinc finger nuclease genome editing technology.

NEW YORK (GenomeWeb) — Researchers have uncovered a gene expression signature linked to risk of cardiovascular death, as they reported last night in Genome Medicine.